These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Catechol-O-methyltransferase gene variation: impact on amygdala response to aversive stimuli. Domschke K, Baune BT, Havlik L, Stuhrmann A, Suslow T, Kugel H, Zwanzger P, Grotegerd D, Sehlmeyer C, Arolt V, Dannlowski U. Neuroimage; 2012 May 01; 60(4):2222-9. PubMed ID: 22387174 [Abstract] [Full Text] [Related]
5. Catechol-O-methyltransferase val158met genotype affects processing of emotional stimuli in the amygdala and prefrontal cortex. Smolka MN, Schumann G, Wrase J, Grüsser SM, Flor H, Mann K, Braus DF, Goldman D, Büchel C, Heinz A. J Neurosci; 2005 Jan 26; 25(4):836-42. PubMed ID: 15673663 [Abstract] [Full Text] [Related]
6. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli. Lo Bianco L, Blasi G, Taurisano P, Di Giorgio A, Ferrante F, Ursini G, Fazio L, Gelao B, Romano R, Papazacharias A, Caforio G, Sinibaldi L, Popolizio T, Bellantuono C, Bertolino A. Psychol Med; 2013 Feb 26; 43(2):279-92. PubMed ID: 22617427 [Abstract] [Full Text] [Related]
7. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia. Ohnishi T, Hashimoto R, Mori T, Nemoto K, Moriguchi Y, Iida H, Noguchi H, Nakabayashi T, Hori H, Ohmori M, Tsukue R, Anami K, Hirabayashi N, Harada S, Arima K, Saitoh O, Kunugi H. Brain; 2006 Feb 26; 129(Pt 2):399-410. PubMed ID: 16330500 [Abstract] [Full Text] [Related]
8. COMT Val158Met polymorphism, verbalizing of emotion and activation of affective brain systems. Swart M, Bruggeman R, Larøi F, Alizadeh BZ, Kema I, Kortekaas R, Wiersma D, Aleman A. Neuroimage; 2011 Mar 01; 55(1):338-44. PubMed ID: 21156209 [Abstract] [Full Text] [Related]
9. COMT Val(108/158)Met polymorphism effects on emotional brain function and negativity bias. Williams LM, Gatt JM, Grieve SM, Dobson-Stone C, Paul RH, Gordon E, Schofield PR. Neuroimage; 2010 Nov 15; 53(3):918-25. PubMed ID: 20139013 [Abstract] [Full Text] [Related]
10. Catechol O-methyltransferase val158met genotype and neural mechanisms related to affective arousal and regulation. Drabant EM, Hariri AR, Meyer-Lindenberg A, Munoz KE, Mattay VS, Kolachana BS, Egan MF, Weinberger DR. Arch Gen Psychiatry; 2006 Dec 15; 63(12):1396-406. PubMed ID: 17146014 [Abstract] [Full Text] [Related]
12. Monoamine oxidase A-uVNTR genotype affects limbic brain activity in response to affective facial stimuli. Lee BT, Ham BJ. Neuroreport; 2008 Mar 26; 19(5):515-9. PubMed ID: 18388730 [Abstract] [Full Text] [Related]
13. 5-HTTLPR and COMTval158met genotype gate amygdala reactivity and habituation. Lonsdorf TB, Golkar A, Lindstöm KM, Fransson P, Schalling M, Ohman A, Ingvar M. Biol Psychol; 2011 Apr 26; 87(1):106-12. PubMed ID: 21356267 [Abstract] [Full Text] [Related]
14. The COMT val158met polymorphism and brain morphometry in healthy young adults. Zinkstok J, Schmitz N, van Amelsvoort T, de Win M, van den Brink W, Baas F, Linszen D. Neurosci Lett; 2006 Sep 11; 405(1-2):34-9. PubMed ID: 16857316 [Abstract] [Full Text] [Related]
16. The effects of catechol O-methyltransferase genotype on brain activation elicited by affective stimuli and cognitive tasks. Heinz A, Smolka MN. Rev Neurosci; 2006 Sep 11; 17(3):359-67. PubMed ID: 16878403 [Abstract] [Full Text] [Related]
17. Differential effect of catechol-O-methyltransferase Val158Met genotype on emotional recognition abilities in healthy men and women. Weiss EM, Stadelmann E, Kohler CG, Brensinger CM, Nolan KA, Oberacher H, Parson W, Pitterl F, Niederstätter H, Kemmler G, Hinterhuber H, Marksteiner J. J Int Neuropsychol Soc; 2007 Sep 11; 13(5):881-7. PubMed ID: 17517149 [Abstract] [Full Text] [Related]
18. COMT Val158Met polymorphism in relation to activation and de-activation in the prefrontal cortex: A study in patients with schizophrenia and healthy subjects. Pomarol-Clotet E, Fatjó-Vilas M, McKenna PJ, Monté GC, Sarró S, Ortiz-Gil J, Aguirre C, Gomar JJ, Guerrero A, Landin R, Capdevila A, Fañanás L, Salvador R. Neuroimage; 2010 Nov 15; 53(3):899-907. PubMed ID: 20398774 [Abstract] [Full Text] [Related]